Rapt Therapeutics (RAPT) PT Raised to $6 at Wells Fargo
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts RAPT Hot Sheet
Price: $58.02 --0%
Rating Summary:
7 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 2
Rating Summary:
7 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 24 | New: 2
Join SI Premium – FREE
Wells Fargo analyst Yanan Zhu raised the price target on Rapt Therapeutics (NASDAQ: RAPT) to $6.00 (from $4.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Qualcomm (QCOM) PT Lowered to $165 at Susquehanna
- Pantoro Gold (PNR:AU) PT Lowered to AUD3.55 at Goldman Sachs
- Greatland Resources Ltd (GGP:AU) PT Lowered to AUD11.80 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
